Education
About Us
Working with TipRanks
Follow Us
Aarti Pharmalabs Limited (IN:AARTIPHARM)
:AARTIPHARM
RESEARCH TOOLSreports
Total Valuation
Aarti Pharmalabs Limited has a market cap or net worth of ₹83.98B. The enterprise value is ₹60.66B.
Market Cap₹83.98B
Enterprise Value₹60.66B
Share Statistics
Aarti Pharmalabs Limited has 90,641,230 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding90,641,230
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Aarti Pharmalabs Limited’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 11.19%.
Return on Equity (ROE)0.14
Return on Assets (ROA)0.09
Return on Invested Capital (ROIC)11.19%
Return on Capital Employed (ROCE)0.17
Revenue Per Employee10.10M
Profits Per Employee1.30M
Employee Count2,095
Asset Turnover0.73
Inventory Turnover1.92
Valuation Ratios
The current PE Ratio of Aarti Pharmalabs Limited is 31.5. Aarti Pharmalabs Limited’s PEG ratio is ―.
PE Ratio31.5
PS Ratio―
PB Ratio―
Price to Fair Value3.43
Price to FCF―
Price to Operating Cash Flow0.00
PEG Ratio―
Income Statement
In the last 12 months, Aarti Pharmalabs Limited had revenue of 21.15B and earned 2.72B in profits. Earnings per share was 30.06.
Revenue21.15B
Gross Profit9.87B
Operating Income3.77B
Pretax Income3.61B
Net Income2.72B
EBITDA4.64B
Earnings Per Share (EPS)30.06
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Aarti Pharmalabs Limited pays an annual dividend of ₹2.5, resulting in a dividend yield of 0.54%
Dividend Per Share₹2.5
Dividend Yield0.54%
Payout Ratio17.01%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.84
52-Week Price Change37.52%
50-Day Moving Average887.30
200-Day Moving Average772.12
Relative Strength Index (RSI)62.61
Average Volume (3m)20.78K
Important Dates
Aarti Pharmalabs Limited upcoming earnings date is Nov 11, 2025, TBA (Not Confirmed).
Last Earnings DateAug 12, 2025
Next Earnings DateNov 11, 2025
Ex-Dividend DateSep 15, 2025
Financial Position
Aarti Pharmalabs Limited as a current ratio of 2.01, with Debt / Equity ratio of 20.76%
Current Ratio2.01
Quick Ratio1.12
Debt to Market Cap0.06
Net Debt to EBITDA0.87
Interest Coverage Ratio14.03
Taxes
In the past 12 months, Aarti Pharmalabs Limited has paid 882.85M in taxes.
Income Tax882.85M
Effective Tax Rate0.24
Enterprise Valuation
Aarti Pharmalabs Limited EV to EBITDA ratio is 15.59, with an EV/FCF ratio of -102.70.
EV to Sales3.42
EV to EBITDA15.59
EV to Free Cash Flow-102.70
EV to Operating Cash Flow21.83
Balance Sheet
Aarti Pharmalabs Limited has ₹562.06M in cash and marketable securities with ₹4.13B in debt, giving a net cash position of ₹3.57B billion.
Cash & Marketable Securities₹562.06M
Total Debt₹4.13B
Net Cash₹3.57B
Net Cash Per Share₹39.38
Tangible Book Value Per Share₹208.39
Margins
Gross margin is 50.71%, with operating margin of 17.85%, and net profit margin of 12.88%.
Gross Margin50.71%
Operating Margin17.85%
Pretax Margin17.05%
Net Profit Margin12.88%
EBITDA Margin21.96%
EBIT Margin18.32%
Analyst Forecast
The average price target for Aarti Pharmalabs Limited is ₹912.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target₹912.00
Price Target Upside-1.57% Downside
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast-0.20%
EPS Growth Forecast18.29%